When used as a preventive treatment in our overuse injury model in weeks 2 and 3 of a 3-week HRHF task, systemic provision of the anti-CCN2 blocked the development of muscle and neural fibrosis in parallel with significant reductions in collagen in each tissue. Here, CCN2 is linked to fibrosis.